{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:55:05Z","timestamp":1758981305853},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s00535-008-2221-6","type":"journal-article","created":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T05:35:54Z","timestamp":1225172154000},"page":"751-761","source":"Crossref","is-referenced-by-count":21,"title":["Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan"],"prefix":"10.1007","volume":"43","author":[{"given":"Mitsushige","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chise","family":"Kodaira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihoko","family":"Yamade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsuhiro","family":"Ikuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Hishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,29]]},"reference":[{"key":"2221_CR1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1053\/j.gastro.2005.01.009","volume":"128","author":"H. Lu","year":"2005","unstructured":"Lu H, Hsu PI, Graham DY, Yamaoka Y. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 2005;128:833\u2013848.","journal-title":"Gastroenterology"},{"key":"2221_CR2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/gut.2005.083014","volume":"55","author":"Y. Yamaoka","year":"2006","unstructured":"Yamaoka Y, Ojo O, Fujimoto S, Odenbreit S, Haas R, Gutierrez O, et al. Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 2006;55:775\u2013781.","journal-title":"Gut"},{"key":"2221_CR3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/35006081","volume":"404","author":"E.M. El-Omar","year":"2000","unstructured":"El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398\u2013402.","journal-title":"Nature"},{"key":"2221_CR4","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0016-5085(03)00157-4","volume":"124","author":"E.M. El-Omar","year":"2003","unstructured":"El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003;124:1193\u20131201.","journal-title":"Gastroenterology"},{"key":"2221_CR5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1440-1746.2006.04442.x","volume":"22","author":"M. Sugimoto","year":"2007","unstructured":"Sugimoto M, Furuta T, Shirai N, Nakamura A, Xiao F, Kajimura M, et al. Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer. J Gastroenterol Hepatol 2007;22:51\u201359.","journal-title":"J Gastroenterol Hepatol"},{"key":"2221_CR6","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/j.1440-1746.2006.04613.x","volume":"22","author":"M. Sugimoto","year":"2007","unstructured":"Sugimoto M, Furuta T, Shirai N, Nakamura A, Kajimura M, Sugimura H, et al. Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol 2007;22:1443\u20131449.","journal-title":"J Gastroenterol Hepatol"},{"key":"2221_CR7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1365-2036.2005.02678.x","volume":"22","author":"M. Sugimoto","year":"2005","unstructured":"Sugimoto M, Furuta T, Shirai N, Nakamura A, Kajimura M, Sugimura H, et al. Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection. Aliment Pharmacol Ther 2005;22:1033\u20131040.","journal-title":"Aliment Pharmacol Ther"},{"key":"2221_CR8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00535-003-1281-x","volume":"39","author":"S. Suzuki","year":"2004","unstructured":"Suzuki S, Muroishi Y, Nakanishi I, Oda Y. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer. J Gastroenterol 2004;39:220\u2013230.","journal-title":"J Gastroenterol"},{"key":"2221_CR9","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1158\/1055-9965.EPI-06-0339","volume":"15","author":"M. Sugimoto","year":"2006","unstructured":"Sugimoto M, Furuta T, Shirai N, Ikuma M, Sugimura H, Hishida A. Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Cancer Epidemiol Biomarkers Prev 2006;15:1929\u20131934.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2221_CR10","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/carcin\/bgm074","volume":"28","author":"M. Sugimoto","year":"2007","unstructured":"Sugimoto M, Furuta T, Shirai N, Kodaira C, Nishino M, Ikuma M, et al. Role of angiotensinogen gene polymorphism on Helicobacter pylori infection-related gastric cancer risk in Japanese. Carcinogenesis 2007;28:2036\u20132040.","journal-title":"Carcinogenesis"},{"key":"2221_CR11","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1053\/j.gastro.2006.02.031","volume":"130","author":"C. McCaig","year":"2006","unstructured":"McCaig C, Duval C, Hemers E, Steele I, Pritchard DM, Przemeck S, et al. The role of matrix metalloproteinase-7 in redefining the gastric microenvironment in response to Helicobacter pylori. Gastroenterology 2006;130:1754\u20131763.","journal-title":"Gastroenterology"},{"key":"2221_CR12","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1242\/jcs.00518","volume":"116","author":"L.E. Wroblewski","year":"2003","unstructured":"Wroblewski LE, Noble PJ, Pagliocca A, Pritchard DM, Hart CA, Campbell F, et al. Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: role in epithelial cell migration. J Cell Sci 2003;116:3017\u20133026.","journal-title":"J Cell Sci"},{"key":"2221_CR13","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0016-5085(03)01206-X","volume":"125","author":"H.C. Crawford","year":"2003","unstructured":"Crawford HC, Krishna US, Israel DA, Matrisian LM, Washington MK, Peek RM Jr. Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa. Gastroenterology 2003;125:1125\u20131136.","journal-title":"Gastroenterology"},{"key":"2221_CR14","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1136\/gut.52.10.1408","volume":"52","author":"J.R. Bebb","year":"2003","unstructured":"Bebb JR, Letley DP, Thomas RJ, Aviles F, Collins HM, Watson SA, et al. Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner. Gut 2003;52:1408\u20131413.","journal-title":"Gut"},{"key":"2221_CR15","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1158\/1078-0432.CCR-04-1922","volume":"11","author":"C. Rocken","year":"2005","unstructured":"Rocken C, Lendeckel U, Dierkes J, Westphal S, Carl-McGrath S, Peters B, et al. The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion\/deletion polymorphism. Clin Cancer Res 2005;11:2526\u20132530.","journal-title":"Clin Cancer Res"},{"key":"2221_CR16","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/carcin\/bgi144","volume":"26","author":"J. Zhang","year":"2005","unstructured":"Zhang J, Jin X, Fang S, Wang R, Li Y, Wang N, et al. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis 2005;26:1748\u20131753.","journal-title":"Carcinogenesis"},{"key":"2221_CR17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1139\/y99-055","volume":"77","author":"M.A. Forget","year":"1999","unstructured":"Forget MA, Desrosiers RR, Beliveau R. Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis. Can J Physiol Pharmacol 1999;77:465\u2013480.","journal-title":"Can J Physiol Pharmacol"},{"key":"2221_CR18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M. Egeblad","year":"2002","unstructured":"Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161\u2013174.","journal-title":"Nat Rev Cancer"},{"key":"2221_CR19","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1021\/bi00439a004","volume":"28","author":"B. Quantin","year":"1989","unstructured":"Quantin B, Murphy G, Breathnach R. Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members. Biochemistry 1989;28:5327\u20135334.","journal-title":"Biochemistry"},{"key":"2221_CR20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1172\/JCI7091","volume":"105","author":"H. Haro","year":"2000","unstructured":"Haro H, Crawford HC, Fingleton B, Shinomiya K, Spengler DM, Matrisian LM. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J Clin Invest 2000;105:143\u2013150.","journal-title":"J Clin Invest"},{"key":"2221_CR21","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0960-9822(00)80113-X","volume":"9","author":"W.C. Powell","year":"1999","unstructured":"Powell WC, Fingleton B, Wilson CL, Boothby M, Matrisian LM. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol 1999;9:1441\u20131447.","journal-title":"Curr Biol"},{"key":"2221_CR22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1242\/jcs.114.1.111","volume":"114","author":"V. Noe","year":"2001","unstructured":"Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001;114:111\u2013118.","journal-title":"J Cell Sci"},{"key":"2221_CR23","first-page":"1296","volume":"61","author":"S. Ye","year":"2001","unstructured":"Ye S, Dhillon S, Turner SJ, Bateman AC, Theaker JM, Pickering RM, et al. Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res 2001;61:1296\u20131298.","journal-title":"Cancer Res"},{"key":"2221_CR24","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-04-1521","volume":"64","author":"C. Yu","year":"2004","unstructured":"Yu C, Zhou Y, Miao X, Xiong P, Tan W, Lin D. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Cancer Res 2004;64:7622\u20137628.","journal-title":"Cancer Res"},{"key":"2221_CR25","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/hq1101.098229","volume":"21","author":"S. Jormsjo","year":"2001","unstructured":"Jormsjo S, Whatling C, Walter DH, Zeiher AM, Hamsten A, Eriksson P. Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 2001;21:1834\u20131839.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2221_CR26","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1373\/clinchem.2003.018911","volume":"49","author":"G. Ghilardi","year":"2003","unstructured":"Ghilardi G, Biondi ML, Erario M, Guagnellini E, Scorza R. Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms. Clin Chem 2003;49:1940\u20131942.","journal-title":"Clin Chem"},{"key":"2221_CR27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1357-2725(02)00271-6","volume":"35","author":"Y. Suzuki","year":"2003","unstructured":"Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol 2003;35:881\u2013900.","journal-title":"Int J Biochem Cell Biol"},{"key":"2221_CR28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0014-2999(91)90552-2","volume":"195","author":"F.A. Noble Le","year":"1991","unstructured":"Le Noble FA, Hekking JW, Van Straaten HW, Slaaf DW, Struyker Boudier HA. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol 1991;195:305\u2013306.","journal-title":"Eur J Pharmacol"},{"key":"2221_CR29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jso.20394","volume":"93","author":"K. Kondo","year":"2006","unstructured":"Kondo K, Muramatsu M, Okamoto Y, Jin D, Takai S, Tanigawa N, et al. Expression of chymase-positive cells in gastric cancer and its correlation with the angiogenesis. J Surg Oncol 2006;93:36\u201342.","journal-title":"J Surg Oncol"},{"key":"2221_CR30","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1172\/JCI116325","volume":"91","author":"H. Urata","year":"1993","unstructured":"Urata H, Boehm KD, Philip A, Kinoshita A, Gabrovsek J, Bumpus FM, et al. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 1993;91:1269\u20131281.","journal-title":"J Clin Invest"},{"key":"2221_CR31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0002-9149(96)00296-2","volume":"78","author":"A. Pfeufer","year":"1996","unstructured":"Pfeufer A, Osterziel KJ, Urata H, Borck G, Schuster H, Wienker T, et al. Angiotensin-converting enzyme and heart chymase gene polymorphisms in hypertrophic cardiomyopathy. Am J Cardiol 1996;78:362\u2013364.","journal-title":"Am J Cardiol"},{"key":"2221_CR32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1291\/hypres.27.101","volume":"27","author":"T. Imanishi","year":"2004","unstructured":"Imanishi T, Hano T, Nishio I. Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. Hypertens Res 2004;27:101\u2013108.","journal-title":"Hypertens Res"},{"key":"2221_CR33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0009-8981(97)00114-9","volume":"265","author":"S. Takai","year":"1997","unstructured":"Takai S, Shiota N, Sakaguchi M, Muraguchi H, Matsumura E, Miyazaki M. Characterization of chymase from human vascular tissues. Clin Chim Acta 1997;265:13\u201320.","journal-title":"Clin Chim Acta"},{"key":"2221_CR34","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","volume":"20","author":"M.F. Dixon","year":"1996","unstructured":"Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161\u20131181.","journal-title":"Am J Surg Pathol"},{"key":"2221_CR35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P. Lauren","year":"1965","unstructured":"Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31\u201349.","journal-title":"Acta Pathol Microbiol Scand"},{"key":"2221_CR36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.brainres.2006.08.007","volume":"1118","author":"Z. Lu","year":"2006","unstructured":"Lu Z, Wang Y, Zhang Q, Zhang X, Wang S, Xie H, et al. Association between the functional polymorphism in the matrix metalloproteinase-7 promoter and susceptibility to adult astrocytoma. Brain Res 2006;1118:6\u201312.","journal-title":"Brain Res"},{"key":"2221_CR37","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1349-7006.1993.tb02805.x","volume":"84","author":"K. Miki","year":"1993","unstructured":"Miki K, Ichinose M, Ishikawa KB, Yahagi N, Matsushima M, Kakei N, et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res 1993;84:1086\u20131090.","journal-title":"Jpn J Cancer Res"},{"key":"2221_CR38","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/0016-5085(92)90156-S","volume":"102","author":"M. Asaka","year":"1992","unstructured":"Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992;102:760\u2013766.","journal-title":"Gastroenterology"},{"key":"2221_CR39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/molehr\/gal002","volume":"12","author":"K. Shan","year":"2006","unstructured":"Shan K, Lian-Fu Z, Hui D, Wei G, Na W, Xia J, et al. Polymorphisms in the promoter regions of the matrix metalloproteinases-7,-9 and the risk of endometriosis and adenomyosis in China. Mol Hum Reprod 2006;12:35\u201339.","journal-title":"Mol Hum Reprod"},{"key":"2221_CR40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0092-8674(00)81279-9","volume":"84","author":"B.M. Gumbiner","year":"1996","unstructured":"Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996;84:345\u2013357.","journal-title":"Cell"},{"key":"2221_CR41","first-page":"5559","volume":"62","author":"T. Vargo-Gogola","year":"2002","unstructured":"Vargo-Gogola T, Fingleton B, Crawford HC, Matrisian LM. Matrilysin (matrix metalloproteinase-7) selects for apoptosisresistant mammary cells in vivo. Cancer Res 2002;62:5559\u20135563.","journal-title":"Cancer Res"},{"key":"2221_CR42","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.4049\/jimmunol.163.10.5723","volume":"163","author":"S. Barille","year":"1999","unstructured":"Barille S, Bataille R, Rapp MJ, Harousseau JL, Amiot M. Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation. J Immunol 1999;163:5723\u20135728.","journal-title":"J Immunol"},{"key":"2221_CR43","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1073\/pnas.94.4.1402","volume":"94","author":"C.L. Wilson","year":"1997","unstructured":"Wilson CL, Heppner KJ, Labosky PA, Hogan BL, Matrisian LM. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci U S A 1997;94:1402\u20131407.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2221_CR44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2005.09.058","volume":"101","author":"Y. Li","year":"2006","unstructured":"Li Y, Jin X, Kang S, Wang Y, Du H, Zhang J, et al. Polymorphisms in the promoter regions of the matrix metalloproteinases-1,-3,-7, and-9 and the risk of epithelial ovarian cancer in China. Gynecol Oncol 2006;101:92\u201396.","journal-title":"Gynecol Oncol"},{"key":"2221_CR45","first-page":"2344","volume":"7","author":"G. Ghilardi","year":"2001","unstructured":"Ghilardi G, Biondi ML, Mangoni J, Leviti S, DeMonti M, Guagnellini E, et al. Matrix metalloproteinase-1 promoter polymorphism 1G\/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 2001;7:2344\u20132346.","journal-title":"Clin Cancer Res"},{"key":"2221_CR46","first-page":"4225","volume":"59","author":"Y. Kanamori","year":"1999","unstructured":"Kanamori Y, Matsushima M, Minaguchi T, Kobayashi K, Sagae S, Kudo R, et al. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion\/ deletion polymorphism in its promoter region. Cancer Res 1999;59:4225\u20134227.","journal-title":"Cancer Res"},{"key":"2221_CR47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/(SICI)1096-9896(199807)185:3<256::AID-PATH115>3.0.CO;2-A","volume":"185","author":"G.I. Murray","year":"1998","unstructured":"Murray GI, Duncan ME, O\u2019Neil P, McKay JA, Melvin WT, Fothergill JE. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol 1998;185:256\u2013261.","journal-title":"J Pathol"},{"key":"2221_CR48","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/sj.bjc.6603307","volume":"95","author":"F.J. Kubben","year":"2006","unstructured":"Kubben FJ, Sier CF, Meijer MJ, van den Berg M, van der Reijden JJ, Griffioen G, et al. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer 2006;95:744\u2013751.","journal-title":"Br J Cancer"},{"key":"2221_CR49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1572-0241.2005.00348.x","volume":"101","author":"S. Hellmig","year":"2006","unstructured":"Hellmig S, Ott S, Rosenstiel P, Robert Folsch U, Hampe J, Schreiber S. Genetic variants in matrix metalloproteinase genes are associated with development of gastric ulcer in H. Pylori infection. Am J Gastroenterol 2006;101:29\u201335.","journal-title":"Am J Gastroenterol"},{"key":"2221_CR50","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0140-6736(98)03228-0","volume":"352","author":"A.F. Lever","year":"1998","unstructured":"Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL, et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998;352:179\u2013184.","journal-title":"Lancet"},{"key":"2221_CR51","first-page":"1139","volume":"2","author":"H. Uemura","year":"2003","unstructured":"Uemura H, Ishiguro H, Nakaigawa N, Nagashima Y, Miyoshi Y, Fujinami K, et al. Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor. Mol Cancer Ther 2003;2:1139\u20131147.","journal-title":"Mol Cancer Ther"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-008-2221-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-008-2221-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-008-2221-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:26:05Z","timestamp":1684607165000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-008-2221-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["2221"],"URL":"https:\/\/doi.org\/10.1007\/s00535-008-2221-6","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}